HERGスクリーニングの世界市場調査レポート-2030年までの予測

Global HERG Screening Market Research Report - Forecast to 2030

HERGスクリーニングの世界市場調査レポート-2030年までの予測市場概要 HERGスクリーニング市場は、予測期間中に12.50%の大幅なCAGRを記録すると予測されています。想像力豊かな薬剤の支持の高まりと冠動脈疾... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
Market Research Future マーケットリサーチフューチャー (MRFR)	2023年10月10日	US$7,250 ライセンス・価格情報注文方法はこちら	107	英語

目次
図表リスト

サマリー

HERGスクリーニングの世界市場調査レポート-2030年までの予測

市場概要
HERGスクリーニング市場は、予測期間中に12.50%の大幅なCAGRを記録すると予測されています。想像力豊かな薬剤の支持の高まりと冠動脈疾患の一般性の上昇が、市場発展に寄与する主要な市場促進要因です。
冠動脈疾患は一般的であり、心臓疾患患者の数は共に増加しているため、市場は発展すると思われる。市場が発展しているのは、新商品を提供する側の研究開発活動が拡大しているためである。さらに、独創的な投薬物質の支持の量の増加が市場の発展を維持することが拡張されている。市場は、病気や問題の解決策を作ることと、薬剤計画の人気の上昇の両方の直接的な結果として発展している。
心毒性の事例が増加しているため、医薬品製造に使用されるスクリーニング材料に大きな関心が集まっている。一般的な検査法がHERG検査よりも望ましいとは限らないが、処方箋に使用される場合には、より安全でより効果的かもしれない。心血管治療薬は、心臓に既往症のある患者に好ましくない後遺症をもたらすことが徐々に増えている。心毒性は、悪性腫瘍の治療や心血管系の医療処置を受けた患者でより普通にみられる。そのため、生産性の高い心毒性検査を可能にするハードウェアや機器への関心が高まっている。心毒性があると、心臓は典型的な機能を果たし、全身に血液を行き渡らせることが難しくなる。そのため心毒性は、血液を吸い上げる心臓の能力を低下させる心筋症の危険性を拡大させる。
市場区分
HERGスクリーニング市場は、遺伝子KCNH2および変異型KCNH2など、タイプ別に細分化される。
イオンチャネルに基づくHERGスクリーニング市場のセグメンテーションには、電圧ゲートおよびリガンドゲートが含まれます。用途別では、抗不整脈薬、抗精神病薬、抗生物質、その他に分類されます。
地域別インサイト

北米のHERGスクリーニング市場は2022年に市場をリードした（45.80%）。American School of Cardiologyによると、一定の間隔で米国住民は心筋死組織に遭遇する。2017年には、356,460人のアメリカ人がクリニック外の心不全を経験し、そのうちの52%で危機的な臨床的利益が呼ばれた。
ヨーロッパHERGスクリーニング市場は、2022年に健全な市場シェアを占めた。ヨーロッパの西部と東部地域はHERGスクリーニング市場の大部分を占めており、どちらも主要な貢献者と見られている。
アジア太平洋地域のHERGスクリーニング市場は、2023年から2032年にかけて重要な発展を遂げると考えられています。宇宙では、個人の重要な部分が持続的な心臓疾患を抱えており、燃えるような問題の発生も急速に増加している。

主要プレイヤー
HERGスクリーニング市場の主要企業は、Eurofins Scientific、Charles River Laboratories、Merck KGaA、Cyprotex Limited、Creative Bioarray、BSYS GmbH、Aurora Biomed、Metrion Biosciencesである。

ページTOPに戻る

TABLE OF CONTENT
1 EXECUTIVE SUMMARY
1.1 MARKET SYNOPSIS 14
1.2 MARKET ATTRACTIVENESS ANALYSIS 15
2 MARKET INTRODUCTION
2.1 DEFINITION 16
2.2 SCOPE OF THE STUDY 16
2.3 RESEARCH OBJECTIVE 16
2.4 MARKET STRUCTURE 16
2.5 ASSUMPTIONS & LIMITATIONS 17
3 RESEARCH METHODOLOGY
3.1 DATA MINING 18
3.2 SECONDARY RESEARCH 19
3.3 PRIMARY RESEARCH 20
3.4 BREAKDOWN OF PRIMARY RESPONDENTS 21
3.5 FORECASTING TECHNIQUES 21
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 22
3.6.1 BOTTOM-UP APPROACH 23
3.6.2 TOP-DOWN APPROACH 23
3.7 DATA TRIANGULATION 24
3.8 VALIDATION 24
4 MARKET DYNAMICS
4.1 OVERVIEW 25
4.2 DRIVERS 26
4.2.1 INCREASING NOVEL DRUG APPROVALS 26
4.2.2 INCREASING PREVALENCE OF HEART DISEASES 26
4.3 RESTRAINT 27
4.3.1 HIGH COST OF HERG SCREENING PRODUCTS 27
4.4 OPPORTUNITY 28
4.4.1 UNTAPPED MARKETS 28
4.5 IMPACT OF CORONAVIRUS (COVID)-19 28
4.5.1 OVERVIEW 28
4.5.2 IMPACT ON PLAYERS 28
4.5.3 IMPACT ON CLINICAL TRIALS 28
5 MARKET FACTOR ANALYSIS
5.1 SUPPLY CHAIN ANALYSIS 29
5.1.1 R&D AND DESIGNING 29
5.1.2 MANUFACTURING 30
5.1.3 DISTRIBUTION 30
5.1.4 MARKETING & SALES 30
5.1.5 POST-SALES MONITORING 30
5.2 PORTER’S FIVE FORCES MODEL 30
5.2.1 BARGAINING POWER OF SUPPLIERS 31
5.2.2 BARGAINING POWER OF BUYERS 31
5.2.3 THREAT OF NEW ENTRANTS 32
5.2.4 THREAT OF SUBSTITUTES 32
5.2.5 RIVALRY 32
5.3 TECHNOLOGICAL TRENDS IN GLOBAL HERG SCREENING MARKET 32
5.3.1 INCREASING TREND OF OUTSOURCING HERG SERVICES 32
5.3.2 ADVENT OF PATCH CLAMP ASSAY 33
5.3.3 STRATEGIC INITIATIVES BY PLAYERS IN THE MARKET 33
5.4 CUSTOMER NEED ANALYSIS 33
5.4.1 OVERVIEW 33
5.4.2 CLINICAL TRIAL FOR HERG SCREENING 33
5.4.3 CAUSE AND EFFECT ANALYSIS 34
6 GLOBAL HERG SCREENING MARKET, BY TYPE
6.1 OVERVIEW 35
6.2 GENE KCNH2 36
6.3 MUTANT KCNH2 36
7 GLOBAL HERG SCREENING MARKET, BY ION CHANNEL
7.1 OVERVIEW 37
7.2 VOLTAGE-GATED ION CHANNEL 39
7.3 LIGAND-GATED ION CHANNEL 39
7.4 OTHERS 40
8 GLOBAL HERG SCREENING MARKET, BY APPLICATION
8.1 OVERVIEW 41
8.2 ANTIARRHYTHMIC 43
8.3 ANTIPSYCHOTIC 43
8.4 ANTIBIOTIC 43
8.5 OTHERS 44
9 GLOBAL HERG SCREENING MARKET, BY REGION
9.1 OVERVIEW 45
9.2 AMERICAS 47
9.2.1 NORTH AMERICA 49
9.2.1.1 US 51
9.2.1.2 CANADA 52
9.2.2 LATIN AMERICA 53
9.3 EUROPE 54
9.3.1 WESTERN EUROPE 56
9.3.1.1 GERMANY 58
9.3.1.2 FRANCE 59
9.3.1.3 UK 60
9.3.1.4 ITALY 61
9.3.1.5 SPAIN 62
9.3.1.6 REST OF WESTERN EUROPE 63
9.3.2 EASTERN EUROPE 64
9.4 ASIA-PACIFIC 65
9.4.1 CHINA 67
9.4.2 JAPAN 68
9.4.3 INDIA 69
9.4.4 AUSTRALIA 70
9.4.5 SOUTH KOREA 71
9.4.6 REST OF ASIA-PACIFIC 72
9.5 MIDDLE EAST & AFRICA 73
9.5.1 MIDDLE EAST 75
9.5.2 AFRICA 76
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW 77
10.2 MARKET RANKING ANALYSIS 77
10.3 COMPETITIVE BENCHMARKING 78
10.4 KEY DEVELOPMENTS AND GROWTH STRATEGIES 79
10.4.1 PARTNERSHIP 79
10.4.2 ACQUISITIONS 80
10.4.3 COLLABORATION 80
10.5 MAJOR PLAYERS FINANCIAL MATRIX & MARKET RATIO 81
10.5.1 SALES & OPERATING PROFIT MARGIN 81
10.5.2 R&D EXPENDITURE 81
11 COMPANY PROFILES
11.1 THERMO FISHER SCIENTIFIC INC. 82
11.1.1 COMPANY OVERVIEW 82
11.1.2 FINANCIAL OVERVIEW 82
11.1.3 PRODUCTS/SERVICES OFFERED 83
11.1.4 KEY DEVELOPMENTS 83
11.1.5 SWOT ANALYSIS 83
11.1.6 KEY STRATEGIES 83
11.2 CHARLES RIVER LABORATORIES INTERNATIONAL, INC. 84
11.2.1 COMPANY OVERVIEW 84
11.2.2 FINANCIAL OVERVIEW 84
11.2.3 PRODUCTS/SERVICES OFFERED 85
11.2.4 KEY DEVELOPMENTS 85
11.2.5 SWOT ANALYSIS 86
11.2.6 KEY STRATEGIES 86
11.3 MERCK KGAA 87
11.3.1 COMPANY OVERVIEW 87
11.3.2 FINANCIAL OVERVIEW 87
11.3.3 PRODUCTS/SERVICES OFFERED 88
11.3.4 KEY DEVELOPMENTS 88
11.3.5 SWOT ANALYSIS 88
11.3.6 KEY STRATEGIES 88
11.4 EUROFINS DISCOVERX CORPORATION 89
11.4.1 COMPANY OVERVIEW 89
11.4.2 FINANCIAL OVERVIEW 89
11.4.3 PRODUCTS/SERVICES OFFERED 90
11.4.4 KEY DEVELOPMENTS 90
11.4.5 SWOT ANALYSIS 90
11.4.6 KEY STRATEGIES 91
11.5 ABCAM PLC. 92
11.5.1 COMPANY OVERVIEW 92
11.5.2 FINANCIAL OVERVIEW 92
11.5.3 PRODUCTS/SERVICES OFFERED 93
11.5.4 KEY DEVELOPMENTS 93
11.5.5 SWOT ANALYSIS 94
11.5.6 KEY STRATEGIES 94
11.6 CYPROTEX LIMITED 95
11.6.1 COMPANY OVERVIEW 95
11.6.2 FINANCIAL OVERVIEW 95
11.6.3 PRODUCTS/SERVICES OFFERED 95
11.6.4 KEY DEVELOPMENTS 95
11.6.5 SWOT ANALYSIS 96
11.6.6 KEY STRATEGIES 96
11.7 B‘SYS GMBH 97
11.7.1 COMPANY OVERVIEW 97
11.7.2 FINANCIAL OVERVIEW 97
11.7.3 PRODUCTS/SERVICES OFFERED 97
11.7.4 KEY DEVELOPMENTS 97
11.7.5 SWOT ANALYSIS 98
11.7.6 KEY STRATEGIES 98
11.8 CREATIVE BIOARRAY 99
11.8.1 COMPANY OVERVIEW 99
11.8.2 FINANCIAL OVERVIEW 99
11.8.3 PRODUCTS/SERVICES OFFERED 99
11.8.4 KEY DEVELOPMENTS 99
11.8.5 SWOT ANALYSIS 100
11.8.6 KEY STRATEGIES 100
11.9 METRION BIOSCIENCES LTD 101
11.9.1 COMPANY OVERVIEW 101
11.9.2 FINANCIAL OVERVIEW 101
11.9.3 PRODUCTS/SERVICES OFFERED 101
11.9.4 KEY DEVELOPMENTS 101
11.9.5 SWOT ANALYSIS 102
11.9.6 KEY STRATEGIES 102
11.10 AURORA BIOMED INC. 103
11.10.1 COMPANY OVERVIEW 103
11.10.2 FINANCIAL OVERVIEW 103
11.10.3 PRODUCTS/SERVICES OFFERED 103
11.10.4 KEY DEVELOPMENTS 103
11.10.5 SWOT ANALYSIS 104
11.10.6 KEY STRATEGIES 104
12 APPENDIX
12.1 REFERENCES 105
12.2 RELATED REPORTS 105

ページTOPに戻る

図表リスト

LIST OF TABLES
TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS 17
TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 20
TABLE 3 GLOBAL HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 36
TABLE 4 GLOBAL HERG SCREENING MARKET, FOR GENE KCNH2, BY REGION, 2022-2030 (USD MILLION) 36
TABLE 5 GLOBAL HERG SCREENING MARKET, FOR MUTANT KCNH2, BY REGION, 2022-2030 (USD MILLION) 36
TABLE 6 GLOBAL HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 38
TABLE 7 GLOBAL HERG SCREENING MARKET, FOR VOLTAGE-GATED ION CHANNEL, BY REGION, 2022-2030 (USD MILLION) 39
TABLE 8 GLOBAL HERG SCREENING MARKET, FOR LIGAND-GATED ION CHANNEL, BY REGION, 2022-2030 (USD MILLION) 39
TABLE 9 GLOBAL HERG SCREENING MARKET, FOR OTHERS, BY REGION, 2022-2030 (USD MILLION) 40
TABLE 10 GLOBAL HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 42
TABLE 11 GLOBAL HERG SCREENING MARKET, FOR ANTIARRHYTHMIC, BY REGION, 2022-2030 (USD MILLION) 43
TABLE 12 GLOBAL HERG SCREENING MARKET, FOR ANTIPSYCHOTIC, BY REGION, 2022-2030 (USD MILLION) 43
TABLE 13 GLOBAL HERG SCREENING MARKET, FOR ANTIBIOTIC, BY REGION, 2022-2030 (USD MILLION) 43
TABLE 14 GLOBAL HERG SCREENING MARKET, FOR OTHERS, BY REGION, 2022-2030 (USD MILLION) 44
TABLE 15 GLOBAL HERG SCREENING MARKET, BY REGION, 2022–2030 (USD MILLION) 46
TABLE 16 AMERICAS: HERG SCREENING MARKET, BY REGION, 2022–2030 (USD MILLION) 47
TABLE 17 AMERICAS: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 47
TABLE 18 AMERICAS: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 48
TABLE 19 AMERICAS: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 48
TABLE 20 NORTH AMERICA: HERG SCREENING MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 49
TABLE 21 NORTH AMERICA: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 49
TABLE 22 NORTH AMERICA: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 50
TABLE 23 NORTH AMERICA: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 50
TABLE 24 US: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 51
TABLE 25 US: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 51
TABLE 26 US: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 51
TABLE 27 CANADA: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 52
TABLE 28 CANADA: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 52
TABLE 29 CANADA: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 52
TABLE 30 LATIN AMERICA: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 53
TABLE 31 LATIN AMERICA: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 53
TABLE 32 LATIN AMERICA: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 53
TABLE 33 EUROPE: HERG SCREENING MARKET, BY REGION, 2022–2030 (USD MILLION) 54
TABLE 34 EUROPE: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 54
TABLE 35 EUROPE: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 55
TABLE 36 EUROPE: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 55
TABLE 37 WESTERN EUROPE: HERG SCREENING MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 56
TABLE 38 WESTERN EUROPE: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 56
TABLE 39 WESTERN EUROPE: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 57
TABLE 40 WESTERN EUROPE: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 57
TABLE 41 GERMANY: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 58
TABLE 42 GERMANY: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 58
TABLE 43 GERMANY: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 58
TABLE 44 FRANCE: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 59
TABLE 45 FRANCE: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 59
TABLE 46 FRANCE: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 59
TABLE 47 UK: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 60
TABLE 48 UK: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 60
TABLE 49 UK: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 60
TABLE 50 ITALY: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 61
TABLE 51 ITALY: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 61
TABLE 52 ITALY: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 61
TABLE 53 SPAIN: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 62
TABLE 54 SPAIN: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 62
TABLE 55 SPAIN: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 62
TABLE 56 REST OF WESTERN EUROPE: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 63
TABLE 57 REST OF WESTERN EUROPE: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 63
TABLE 58 REST OF WESTERN EUROPE: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 63
TABLE 59 EASTERN EUROPE: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 64
TABLE 60 EASTERN EUROPE: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 64
TABLE 61 EASTERN EUROPE: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 64
TABLE 62 ASIA-PACIFIC: HERG SCREENING MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 65
TABLE 63 ASIA-PACIFIC: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 65
TABLE 64 ASIA-PACIFIC: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 66
TABLE 65 ASIA-PACIFIC: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 66
TABLE 66 CHINA: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 67
TABLE 67 CHINA: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 67
TABLE 68 CHINA: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 67
TABLE 69 JAPAN: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 68
TABLE 70 JAPAN: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 68
TABLE 71 JAPAN: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 68
TABLE 72 INDIA: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 69
TABLE 73 INDIA: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 69
TABLE 74 INDIA: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 69
TABLE 75 AUSTRALIA: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 70
TABLE 76 AUSTRALIA: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 70
TABLE 77 AUSTRALIA: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 70
TABLE 78 SOUTH KOREA: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 71
TABLE 79 SOUTH KOREA: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 71
TABLE 80 SOUTH KOREA: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 71
TABLE 81 REST OF ASIA-PACIFIC: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 72
TABLE 82 REST OF ASIA-PACIFIC: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 72
TABLE 83 REST OF ASIA-PACIFIC: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 72
TABLE 84 MIDDLE EAST & AFRICA: HERG SCREENING MARKET, BY REGION, 2022–2030 (USD MILLION) 73
TABLE 85 MIDDLE EAST & AFRICA: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 73
TABLE 86 MIDDLE EAST & AFRICA: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 74
TABLE 87 MIDDLE EAST & AFRICA: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 74
TABLE 88 MIDDLE EAST: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 75
TABLE 89 MIDDLE EAST: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 75
TABLE 90 MIDDLE EAST: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 75
TABLE 91 AFRICA: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 76
TABLE 92 AFRICA: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 76
TABLE 93 AFRICA: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 76
TABLE 94 TOP PLAYERS IN THE GLOBAL HERG SCREENING MARKET 77
TABLE 95 PARTNERSHIP: GLOBAL HERG SCREENING MARKET 79
TABLE 96 ACQUISITIONS: GLOBAL HERG SCREENING MARKET 80
TABLE 97 COLLABORATION: GLOBAL HERG SCREENING MARKET 80
TABLE 98 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED 83
TABLE 99 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: PRODUCTS/SERVICES OFFERED 85
TABLE 100 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: KEY DEVELOPMENTS 85
TABLE 101 MERCK KGAA: PRODUCTS/SERVICES OFFERED 88
TABLE 102 EUROFINS DISCOVERX CORPORATION: PRODUCTS/SERVICES OFFERED 90
TABLE 103 EUROFINS DISCOVERX CORPORATION: KEY DEVELOPMENTS 90
TABLE 104 ABCAM PLC.: PRODUCTS/SERVICES OFFERED 93
TABLE 105 ABCAM PLC.: KEY DEVELOPMENTS 93
TABLE 106 CYPROTEX LIMITED: PRODUCTS/SERVICES OFFERED 95
TABLE 107 B‘SYS GMBH: PRODUCTS/SERVICES OFFERED 97
TABLE 108 CREATIVE BIOARRAY: PRODUCTS/SERVICES OFFERED 99
TABLE 109 METRION BIOSCIENCES LTD: PRODUCTS/SERVICES OFFERED 101
TABLE 110 AURORA BIOMED INC.: PRODUCTS/SERVICES OFFERED 103

ページTOPに戻る

Table of Contents
List of Tables/Graphs

Summary

Global HERG Screening Market Research Report - Forecast to 2030

Market Overview
The HERG Screening Market is anticipated to register a significant CAGR of 12.50% during the forecast period. The rising endorsement of imaginative medications and the ascent in coronary illness commonness are the major market drivers contributing the market development.
As coronary illness is common and the quantity of heart condition patients both ascents, the market is supposed to develop. The market is developing because of expanded Research and development exercises on the side of new item deliveries. Furthermore, it is extended that an ascent in the quantity of creative medication substance endorsements will uphold the market's development. The market is developing as a direct result of both the making of solutions for diseases and problems and the ascent of popularity for drug plans.
Because of the development in examples of cardiotoxicity, there has been a critical interest in screening materials utilized in drug creation. Customary testing techniques may not generally be preferable over HERG tests, yet they might be more secure and more effective when utilized on prescriptions. Cardiovascular medications are progressively having unfavorable aftereffects in patients with prior heart conditions. Cardiotoxicity is more normal in patients who have had malignant growth treatment or cardiovascular medical procedures. Subsequently, there is a rising interest in hardware and administrations that empower productive cardiotoxicity testing. The heart makes some harder memories completing typical capabilities and disseminating blood all through the body when there is cardiotoxicity. Cardiotoxicity thus expands the gamble of cardiomyopathy, which decreases the heart's ability to siphon blood.
Market Segmentation
The HERG Screening market segmentation, based on Type, includes Gene KCNH2 and Mutant KCNH2.
The HERG Screening market segmentation, based on Ion Channel, includes Voltage Gated and Ligand Gated. Based on Application the market is classified into Antiarrhythmic, Antipsychotic, Antibiotics, and Others.
Regional Insights

The North American HERG Screening Market led the market in 2022 (45.80%). At regular intervals, a resident of the US will encounter a myocardial dead tissue, as per the American School of Cardiology. In 2017, 356,460 Americans went through an out-of-clinic heart failure, and in 52% of those cases, crisis clinical benefits were called.
Europe HERG Screening market represented the sound market share in 2022. Europe's western and eastern regions make up most of the market for HERG screening and are both viewed as major contributors.
The Asia Pacific HERG Screening market is supposed to enroll in critical development from 2023 to 2032. A critical part of individuals in space has persistent heart conditions, and the occurrence of fiery problems is rising rapidly too.

Major Players
Major players in the HERG Screening market are Eurofins Scientific, Charles River Laboratories, Merck KGaA, Cyprotex Limited, Creative Bioarray, BSYS GmbH, Aurora Biomed, and Metrion Biosciences.

ページTOPに戻る

List of Tables/Graphs

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療）の最新刊レポート

Market Research Future社の医療分野での最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問

Market Research Future社はどのような調査会社ですか?

マーケットリサーチフューチャー（Market Research Future）は世界市場を幅広く調査し、主要分野、地域、国レベルの調査レポートを出版しています。下記分野については、分野毎に専... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

HERGスクリーニングの世界市場調査レポート-2030年までの予測

サマリー

目次

図表リスト

Summary

Table of Contents

List of Tables/Graphs

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（医療）の最新刊レポート

Market Research Future社の医療分野での最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

よくあるご質問

Market Research Future社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?